Featured Research

from universities, journals, and other organizations

Radiotherapy plus hormone therapy cuts prostate cancer death in half, shows long-term study

Date:
January 29, 2014
Source:
Oslo University Hospital
Summary:
Combination of radiotherapy and hormone treatment more than halves mortality rates for prostate cancer, reports a new article.

Combination treatment more than halves mortality rates for prostate cancer, reports Norwegian health journal Dagens Medisin.

The figures were presented by Norwegian cancer researcher Sophie Fosså at an international conference sponsored by the American Society of Clinical Oncology (ASCO) in San Francisco this week.

By adding radiotherapy to the standard hormone treatment against prostate cancer, the 10 to 15 year survival rate for men with prostate cancer more than doubled, according to a long term follow-up study where Dr. Sophie Fosså is lead author. She is a professor at Oslo University Hospital in Norway.

Behind the study are Dr. Fosså and researchers from The Scandinavian Prostate Cancer Group. "When this study started in 1996, the standard treatment was hormone therapy alone, but this trial continues to show that adding radiotherapy substantially boosts long-term survival," says Dr. Fosså.

"This combination more than doubles the 10-year survival rate and confirms that this approach should be a standard option for men with this type of prostate cancer who are expected to live at least another 10 years."

In all, 875 male patients from Norway, Sweden and Denmark participated in the study. Of these, 653 participants were Norwegians.

  • Among the 439 men who underwent hormone therapy alone, 118 died of prostate cancer.
  • Among the 436 who underwent the combination treatment, 45 died of cancer.
  • Among the patients that underwent hormone therapy only, the 10 and 15 year mortality rates were 18.9 percent and 30.7 percent, respectively.
  • Among those that underwent the combination treatment, the figures amounted to 8.3 percent and 12.4 percent, respectively.

The figures presented by Dr. Fosså at the ASCO conference are a follow-up to an earlier study published in The Lancet in 2009, where Fosså and her colleagues demonstrate how radiotherapy in combination with hormone treatment reduced prostate cancer mortality from 24 to 12 percent.


Story Source:

The above story is based on materials provided by Oslo University Hospital. Note: Materials may be edited for content and length.


Journal Reference:

  1. Anders Widmark, Olbjørn Klepp, Arne Solberg, Jan-Erik Damber, Anders Angelsen, Per Fransson, Jo-Åsmund Lund, Ilker Tasdemir, Morten Hoyer, Fredrik Wiklund, Sophie D Fosså. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. The Lancet, 2009; 373 (9660): 301 DOI: 10.1016/S0140-6736(08)61815-2

Cite This Page:

Oslo University Hospital. "Radiotherapy plus hormone therapy cuts prostate cancer death in half, shows long-term study." ScienceDaily. ScienceDaily, 29 January 2014. <www.sciencedaily.com/releases/2014/01/140129134909.htm>.
Oslo University Hospital. (2014, January 29). Radiotherapy plus hormone therapy cuts prostate cancer death in half, shows long-term study. ScienceDaily. Retrieved August 27, 2014 from www.sciencedaily.com/releases/2014/01/140129134909.htm
Oslo University Hospital. "Radiotherapy plus hormone therapy cuts prostate cancer death in half, shows long-term study." ScienceDaily. www.sciencedaily.com/releases/2014/01/140129134909.htm (accessed August 27, 2014).

Share This




More Health & Medicine News

Wednesday, August 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

WHO Calls for Ban on E-Cigarette Sales to Minors

WHO Calls for Ban on E-Cigarette Sales to Minors

AFP (Aug. 26, 2014) — The World Health Organization called Tuesday on governments should ban the sale of e-cigarettes to minors, warning that they pose a "serious threat" to foetuses and young people. Duration: 01:44 Video provided by AFP
Powered by NewsLook.com
Have You Ever Been 'Sleep Drunk?' 1 in 7 Has

Have You Ever Been 'Sleep Drunk?' 1 in 7 Has

Newsy (Aug. 26, 2014) — A study published in the journal "Neurology" interviewed more than 19,000 people and found 15 percent suffer from being "sleep drunk." Video provided by Newsy
Powered by NewsLook.com
Does Medical Marijuana Reduce Painkiller Overdose Deaths?

Does Medical Marijuana Reduce Painkiller Overdose Deaths?

Newsy (Aug. 26, 2014) — A new study found fewer deaths from prescription drug overdoses in states that have legalized medical marijuana. But experts disagree on the results. Video provided by Newsy
Powered by NewsLook.com
Official: British Ebola Sufferer Receiving Experimental Drug

Official: British Ebola Sufferer Receiving Experimental Drug

AFP (Aug. 26, 2014) — A British nurse infected with Ebola while working in Sierra Leone is being given the same experimental drug used on two US missionaries who have recovered for the disease, doctors in London say. Duration: 00:44 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:  

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile iPhone Android Web
    Follow Facebook Twitter Google+
    Subscribe RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins